Aditxt, Inc.
Market Cap
$525
P/E Ratio
—
EPS
$-9230.64
Dividend Yield
0.00%
52-Week Range
$0.19 — $2495.04
Volume
764.40K
Avg Volume
1.43M
Beta
1.40
Get alerted when ADTX hits your target price.
Free — enter your email to get started
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.00
P/S (TTM)
0.00
P/B (TTM)
0.03
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-6286.36%
ROA (TTM)
-2609.56%
ROIC
—
Gross Margin
0.08%
Operating Margin
-6125.42%
Net Margin
—
Debt/Equity
535.95
Current Ratio
0.31
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-5589.68%
EPS Growth (5Y)
-3353.77%
Sales Growth (3Y)
+2.26%
Sales Growth (5Y)
+1.36%
EPS Est (This Year)
$-105688900.00
EPS Est (Next Year)
$-107485600.00
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$8562.71
Institutional %
0.00%
Inst. Net Change
-1000
Insider Net Shares (90d)
—
Outstanding Shares
21.52K
Float
21.52K
Free Float %
100.00%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2020-06-30
Employees
26
CEO
Amro A. Albanna
Index Membership
—
Website
https://www.aditxt.com
Aditxt, Inc. (ADTX) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $525, ADTX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ADTX against other stocks using dozens of fundamental and technical filters.
No, Aditxt, Inc. (ADTX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Aditxt, Inc. (ADTX) has a market capitalization of $525, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.